Hope is born in ovarian cancer

Advanced stage ovarian cancer a patient on a small group of patients medicine , almost half of the participants tumor It's gotten smaller.

Britain In a study conducted by the NHS Foundation of Cancer Research and Royal Marsden, 15 women with advanced stage ovarian cancer were treated with a drug called ONX-0801, and the 7-year-old women with a specifically targeted molecule had a significantly reduced size.

Does not harm healthy cells

Side effects, such as infection, diarrhea, nerve damage and hair loss, which are common in traditional chemotherapy, have also been reported in treatment with drugs that only target cancerous cells and do not harm healthy cells.

Experts stressed that the use of the medication for several months or more may not be safe, and that more extensive clinical trials are expected.

Researchers have also developed a test that detects whether women with ovarian cancer carry the molecule in question.

Ovarian cancer, whose symptoms are not easily understood, is not noticed until 6th in every 10th females.